Navigating New DEA Guidance: Registration Requirements for Practitioners Receiving Controlled Medications
In February 2024, the Drug Enforcement Administration (DEA) issued crucial guidance answering a pertinent question: must practitioners receiving controlled medications from pharmacies be registered with the DEA at each location of receipt? This guidance, EO-DEA285, DEA-DC82, stemming from 21 U.S.C. 829a(a), carries significant implications for practitioners, pharmacies, and regulatory compliance. Understanding the Guidance: The DEA’s […]
Is the Federal Anti-Kickback Law Unconstitutionally Vague?
What is the Federal Anti-Kickback Law? The federal anti-kickback law is a criminal statute that prohibits healthcare providers, including physicians and hospitals, from receiving or giving anything of value in exchange for referrals or recommendations of healthcare services paid for by federal healthcare programs such as Medicare, Medicaid, and TRICARE. The major provisions of the […]
